Evidence map›Paper›PMID 42060842›Full record

ReviewJournal of bacteriology2026

Melissa Arroyo-Mendoza, Hernan Lorenzi, Gregory J Phillips, Deborah M Hinton

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Microbiology (Reading, England) · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Melissa Arroyo-MendozaGene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-9461-1202
Hernan LorenziTriLab Bioinformatics Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-0910-7894
Gregory J PhillipsDepartment of Infectious Diseases, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-0048-512X
Deborah M HintonGene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-7254-9495

Funding

Highly simplified model of a mammalian intestinal communityR01GM099537 · NIGMS · IOWA STATE UNIVERSITY · PI PHILLIPS, JAMES GREGORY · 2013 to 2016
$1.0M
Microbiome Dynamics During Cancer ProgressionR03CA195305 · NCI · IOWA STATE UNIVERSITY · PI PHILLIPS, JAMES GREGORY · 2017 to 2018
$142k
Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases within the National Institutes of HealthNIH HHS R01 GM099537NIH HHS R03 CA195305U.S. Department of Defense-Defense Threat Reduction Agency (DTRA) HDTRA12110015
6 · The paper itself

Abstract

Crohn's disease (CD), an inflammatory bowel disease that arises from an immune attack on the gastrointestinal tract, affects roughly 1.6 million Americans. The etiology of CD and the other major irritable bowel disease, ulcerative colitis, is not known, but host genetics and immunology, the gut microbiome, and environmental factors are all thought to be involved. In addition, adherent-invasive

Indexed as

Crohn DiseaseEscherichia coliEscherichia coli InfectionsAnimalsBacterial AdhesionGastrointestinal MicrobiomeHumansMacrophagesPhenotypePolymorphism, Single NucleotideCrohn's diseaseE. coli pathobiontLF82RNA polymerase

Identifiers

PMID42060842
PMCPMC13192267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.